Citius Pharmaceuticals, Inc. , a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy.
Citius Pharmaceuticals stock last closed at $0.88, down 8.42% from the previous day, and has decreased 42.42% in one year. It has underperformed other stocks in the Biotechnology industry by 0.15 percentage points. Citius Pharmaceuticals stock is currently +39.84% from its 52-week low of $0.63, and -64.48% from its 52-week high of $2.48.
There are currently 22.38M shares of CTXR outstanding. The market cap of CTXR is $19.71M. In the last 24 hours, 664,000 CTXR shares were traded.
You need a brokerage account to access the NASDAQ market and buy CTXR shares.
Based on our experience, eToro is the best brokerage. Here's why:
Get $10 towards your share purchase by opening an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've chosen the right brokerage, you'll need to fill out some personal information so you are able to invest in CTXR today.
Now that you have filled out your info on our top ranked stock trading app, your next step is to transfer the money for your investment:
Check out the video below if you need help transferring money into your brokerage account.
After you have chosen the best place to buy Citius Pharmaceuticals stock, it's crucial to research their stock prior to buying, so you actually understand the risk as well as the upside.
WallStreetZen was created to help average investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on CTXR's stock page.
You can use many financial metrics, analyses, models, and charts to gauge CTXR's true value.
Using relative valuations measures:
You can access more valuation analysis on CTXR's stock here.
Out of 1 Equities analysts who give ratings on CTXR, the consensus analyst rating on Citius Pharmaceuticals is a Strong Buy
It's important to note that analyst forecasts are not recommendations, nor are they financial advice.
You can dive deeper into what analysts are projecting on the Citius Pharmaceuticals stock forecast page.
In the last year, insiders at CTXR have not bought or sold any shares.
Dig into more about who owns CTXR shares here.
No, Citius Pharmaceuticals doesn't provide an income stream by paying out dividends.
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to learn what other investors have to say.
You have two primary order types:
Click the Open Trade button and your broker will place the order.
If you want more info about buying stocks on eToro, click the helpful video below:
Now that you own some CTXR shares, you'll want to stay up-to-date on your new stock purchase.
Put CTXR on a watchlist to track your CTXR stock.
To reiterate, here are the 6 steps for buying Citius Pharmaceuticals stock:
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to monitor your investment in Citius Pharmaceuticals, create a watchlist on WallStreetZen today.